Nutraplus India

Nutraplus_India13 Dec 2021

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Nutraplus India

Nutraplus India

Pharmaceuticals

Nutraplus_India13 Dec 2021

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
23-Aug-2016	S	Nutraplus India Ltd has informed BSE that the meeting of the Board of Directors was held on August 22, 2016. Considered and approved sub-division of one Equity Share of the Company having face value of Rs. 10/- each into 2 Equity Shares of Rs. 5/- each fully paid up and consequently amendment in the Capital Clause of the Memorandum of Association of the Company, subject to approval of shareholders. Trading Members of the Exchange are hereby informed that Nutraplus India Ltd has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Nutraplus India Ltd (524764) RECORD DATE 28/02/2017 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TWO equity shares of Rs.5/- each SUB-DIVIDED PAID-UP VALUE Rs.5/- SUB-DIVIDED PAID-UP VALUE W.E.F. 27/02/2017 DR- 227/2016-2017 Note:- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 5/- paid up w.e.f. 27/02/2017. ii. ISIN No. INE230G01012 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 27/02/2017. iii. The new ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 15.02.2017)	28-Feb-2017
17-May-2016	D	Nutraplus India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2016, inter alia, has recommended a Final Dividend of Re. 0.50/- per fully paid up equity share of Rs. 10/- each, for the year ended March 31, 2016.	06-Sep-2016
10-Jan-2017	B	Trading Members of the Exchange are hereby informed that, Nutraplus India Ltd. has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Nutraplus India Ltd. (524764) RECORD DATE 20/01/2017 PURPOSE Issue of 1 (ONE) Bonus equity share for every 10 (TEN) existing equity shares held. Ex-Bonus basis from Date & Sett. No. 19/01/2017 DR-202/2016-2017 Trading Members of the Exchange are requested to take note of it.	20-Jan-2017	1:10
28-Feb-2024	BC	Dear Sir, Please find attached Annual Report 2021 of Nutraplus India Limited. Regards, Nutraplus India Limited	26-Nov-2021
28-Feb-2024	BC	Dear Sir, Please find attached Annual Report 2021 of Nutraplus India Limited. Regards, Nutraplus India Limited	14-Nov-2021
16-Aug-2021	BC	This is in continuation to Exchange Notice No. 20210112-47, 20210112-48 & 20210112-49 dated January 12, 2021 wherein the Trading Members were advised that w.r.t to the following companies, 15 days af	31-Aug-2021
17-Nov-2020	BC	Further to our letter dated 16th November, 2020, we would like to further inform you that at the Board Meeting held on November 16, 2020 the Board of Directors have re-appointed Mr. Vinod L. Parab (D	01-Apr-2021
10-Jan-2021	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S	15-Mar-2021

No Rights has been declared by Nutraplus_India

Book Closure

Record Date	Split Date	Purpose
26-Nov-2021	-	Dear Sir, Please find attached Annual Report 2021 of Nutraplus India Limited. Regards, Nutraplus India Limited
14-Nov-2021	01 Jan'1900	Dear Sir, Please find attached Annual Report 2021 of Nutraplus India Limited. Regards, Nutraplus India Limited
31-Aug-2021	-	This is in continuation to Exchange Notice No. 20210112-47, 20210112-48 & 20210112-49 dated January 12, 2021 wherein the Trading Members were advised that w.r.t to the following companies, 15 days af
01-Apr-2021	-	Further to our letter dated 16th November, 2020, we would like to further inform you that at the Board Meeting held on November 16, 2020 the Board of Directors have re-appointed Mr. Vinod L. Parab (D
15-Mar-2021	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Nutraplus India Ltd ₹2.10(0.00/0.00%)	2.10	+0.00	7.16	-60.67	0.00	-3.49
Astrazeneca Pharma India Ltd ₹5,341.25(-214.85/-3.87%)	5,341.25	-214.85	13,353.13	68.03	83.72	20.39
Bliss GVS Pharma Ltd ₹123.70(-0.75/-0.60%)	123.70	-0.75	1,295.03	60.30	18.97	1.32
Cipla Ltd ₹1,401.20(-6.35/-0.45%)	1,401.20	-6.35	113,132.18	52.94	34.40	4.37
Abbott India Ltd ₹26,415.75(+138.15/0.53%)	26,415.75	+138.15	56,133.47	18.05	49.00	18.06
Amrutanjan Health Care Ltd ₹697.95(-11.45/-1.61%)	697.95	-11.45	2,017.82	15.18	45.86	7.70

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18
Gross Sales	13.76	21.88	39.44	31.59	35.80	42.94
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	13.76	21.88	39.44	31.59	35.80	42.94
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.07	0.02	0.02	0.04	3.80	0.02
Total Income	13.82	21.90	39.46	31.62	39.60	42.96
Total Expenditure	43.18	34.59	36.06	28.67	36.53	39.86
PBIDT	-29.36	-12.69	3.40	2.95	3.07	3.10
Interest	1.43	2.22	2.19	1.60	0.65	1.67
PBDT	-30.79	-14.90	1.21	1.36	2.42	1.43
Depreciation	1.20	1.16	1.16	1.18	0.72	1.02
Tax	-0.02	0.02	0.00	0.00	0.02	0.00
Deferred Tax	0.00	0.00	0.00	0.00	1.15	0.00
Reported Profit After Tax	-31.98	-16.08	0.06	0.18	0.52	0.41
Extra-ordinary Items	0.00	0.00	0.00	0.00	-0.70	0.00
Adjusted Profit After Extra-ordinary item	-31.98	-16.08	0.06	0.18	1.22	0.41

EPS (Unit Curr.)	-9.38	-4.72	0.02	0.05	0.16	0.12
EPS (Adj) (Unit Curr.)	-9.38	-4.72	0.02	0.05	0.16	0.12
Calculated EPS (Unit Curr.)	-9.38	-4.72	0.02	0.05	0.15	0.12
Calculated EPS (Adj) (Unit Curr.)	-9.38	-4.72	0.02	0.05	0.15	0.12
Calculated EPS (Ann.) (Unit Curr.)	-37.52	-18.87	0.06	0.21	0.61	0.48
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-37.52	-18.87	0.06	0.21	0.61	0.48
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	17.05	17.05	17.05	17.05	17.05	17.05
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	5.00	5.00	5.00	5.00	5.00	5.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-213.37	-58.00	8.62	9.34	8.58	7.22
PBDTM(%)	-223.76	-68.10	3.07	4.31	6.76	3.33
PATM(%)	-232.41	-73.49	0.15	0.57	1.45	0.95

Column	Jun 15	Mar 15	Dec 14	Sep 14	Jun 14	Mar 14
Gross Sales	15.28	18.34	16.57	12.68	17.46	26.29
Excise Duty	0.00	0.00	0.00	0.00	0.00	6.73
Net Sales	15.28	18.34	16.57	12.68	17.46	19.57
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.03	0.12	0.03	0.01	0.04	0.03
Total Income	15.31	18.46	16.60	12.69	17.49	19.59
Total Expenditure	12.52	16.12	12.51	41.54	14.94	14.63
PBIDT	2.79	2.34	4.09	-28.85	2.56	4.97
Interest	0.52	0.64	2.00	1.14	0.74	2.36
PBDT	2.27	1.70	2.09	-29.98	1.82	2.61
Depreciation	0.37	0.46	0.32	0.11	0.52	0.41
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.39	-2.02	0.15	0.00	0.28	1.03
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	1.51	3.26	1.63	-30.09	1.03	1.17
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	1.51	3.26	1.63	-30.09	1.03	1.17

Extra-ordinary Items	0.01	0.00	0.00	-23.26	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.50	3.26	1.63	-6.83	1.03	1.17

EPS (Unit Curr.)	1.26	4.02	2.46	-51.05	1.74	1.99
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.20	11.16	6.60	5.90	5.20	5.90

Public Shareholding (Number)	7253348.00	7253348.00	2687500.00	2687500.00	2685500.00	2687500.00
Public Shareholding (%)	60.63	65.00	40.75	45.59	45.59	45.59

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	4710000.00	3907500.00	3907500.00	3207500.00	3207500.00	3207500.00
Non Encumbered - % in Total Promoters Holding	100.00	100.00	100.00	100.00	100.00	100.00
Non Encumbered - % in Total Equity	39.37	35.00	59.25	54.41	54.41	54.41

PBIDTM(%)	18.26	12.76	24.68	-227.52	14.66	25.40
PBDTM(%)	14.86	9.27	12.61	-236.44	10.42	13.34
PATM(%)	9.88	17.78	9.84	-237.30	5.90	5.98

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
SOURCES OF FUNDS :
Share Capital	17.05	17.05	17.05	17.05	17.05	12.67
Reserves Total	-19.10	4.57	52.40	50.19	50.17	45.54
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	4.68
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-2.05	21.62	69.45	67.24	67.22	62.89
Secured Loans	0.00	75.88	74.93	73.38	65.77	66.68
Unsecured Loans	1.75	0.00	0.00	0.00	0.00	5.37
Total Debt	1.75	75.88	74.93	73.38	65.77	72.05
Total Liabilities	-0.30	97.50	144.38	140.62	132.99	134.94
APPLICATION OF FUNDS :
Gross Block	0.00	95.66	92.34	78.31	40.85	37.09
Less : Accumulated Depreciation	0.00	14.47	9.90	6.00	2.21	4.20
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	81.19	82.44	72.31	38.64	32.89
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.12	12.67	17.26	21.59	48.27	37.53
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.15	0.15	4.15	4.15	4.16	4.15
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.55	28.77	37.08	24.94	22.41	25.93
Sundry Debtors	1.08	2.77	16.43	25.03	26.14	25.44
Cash and Bank	0.10	0.83	2.02	2.05	2.06	2.89
Loans and Advances	4.47	10.49	10.33	21.46	27.54	36.63
Total Current Assets	9.21	42.86	65.85	73.48	78.15	90.90
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	9.70	13.23	23.85	30.90	36.43	28.24
Provisions	0.08	25.30	0.63	0.32	0.85	1.75
Total Current Liabilities	9.78	38.53	24.48	31.22	37.27	29.99
Net Current Assets	-0.57	4.33	41.37	42.26	40.87	60.91
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.85	0.00	0.00	0.30	1.04	0.00
Deferred Tax Liability	0.85	0.85	0.85	0.00	0.00	0.66
Net Deferred Tax	0.00	-0.85	-0.85	0.30	1.04	-0.66
Total Assets	-0.30	97.49	144.37	140.61	132.98	134.81
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	6.41

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash and Cash Equivalents at Beginning of the year	0.83	2.02	2.05	2.06	2.89
Net Cash from Operating Activities	-14.25	9.07	12.36	6.69	19.66
Net Cash Used In Investing Activities	93.77	-2.69	-9.74	-10.70	-18.59
Net Cash Used In Financing Activities	-80.25	-7.57	-2.66	4.00	-1.91
Net Inc./Dec In Cash And Cash Equivalents	-0.73	-1.18	-0.03	-0.01	-0.84
Cash And Cash Equivalents At End Of The Year	0.10	0.83	2.02	2.05	2.06

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

40.07%

FII Shareholding

0.00%

DII Shareholding

0.03%

Public Shareholding

59.91%

**Promoter pledged shareholding 40.07%

About Nutraplus India Ltd

Nutraplus India Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 7.16 crores. It has reported a sales of Rs. 13.76 crores and a net profit of Rs. -31.98 crores for the quarter ended December 2018. The company management includes Mukesh D Naik, Mukesh D Naik,Vinod Laxman Parab,Nitin Desai,Nancy Napoleon,Leena Chitalia (Nutraplus India Ltd) among others.

Chairman

Mukesh D Naik

Registered office

Plot No N-92,MIDC-Tarapur Boisar,Thane,Maharashtra,401506

FAX :

Background

Incorporation Year1990

Face Value₹5

Market Lot1

How to buy Nutraplus India shares on nse?

To buy Nutraplus India shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Nutraplus India share price today?

The Nutraplus India shares price on nse is Rs.2.1 today.

What is the market cap of Nutraplus India shares on BSE ?

The company has a market capitalization of Rs.7.16Cr

What is the PE & PB ratio of Nutraplus India shares ?

PE is 0 and PB is -3.49

What is the 52 Week High and Low of Nutraplus India shares?

Nutraplus India stock price high: Rs.2.1 Nutraplus India stock price low: Rs.0